Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled TrialStefan Bielack, Mark L. Bernstein, James S. Meyer et al.|Journal of Clinical Oncology|2015Cited by 419
Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiencyMichal Kováč, Daniel Baumhoer|Nature Communications|2015Cited by 343
The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision supportAnja Irmisch, Martina Haberecker, Ximena Bonilla et al.|Cancer Cell|2021Cited by 140
Single-cell landscape of innate and acquired drug resistance in acute myeloid leukemiaRebekka Wegmann, Stefanie Engler, Ximena Bonilla et al.|Nature Communications|2024Cited by 25
Feasibility of multiomics tumor profiling for guiding treatment of melanomaNicola Miglino, Nora C. Toussaint, Alexander Ring et al.|Nature Medicine|2025Cited by 15